- Home
- CPRX vs CRGY Comparison
CPRX vs CRGY Comparison
Compare CPRX & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CPRX | CRGY |
|---|---|---|
| Founded | 2002 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.3B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | CPRX | CRGY |
|---|---|---|
| Price | $24.49 | $10.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $33.25 | $13.17 |
| AVG Volume (30 Days) | 1.2M | ★ 5.9M |
| Earning Date | 02-25-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 4.74% |
| EPS Growth | ★ 44.94 | N/A |
| EPS | ★ 1.71 | 0.10 |
| Revenue | $578,196,000.00 | ★ $3,590,024,000.00 |
| Revenue This Year | $19.98 | $25.76 |
| Revenue Next Year | $6.96 | $24.66 |
| P/E Ratio | ★ $14.31 | $97.44 |
| Revenue Growth | 25.56 | ★ 32.31 |
| 52 Week Low | $19.05 | $6.83 |
| 52 Week High | $26.58 | $15.58 |
Technical Indicators
Market Signals| Indicator | CPRX | CRGY |
|---|---|---|
| Relative Strength Index (RSI) | 53.15 | 61.69 |
| Support Level | $23.86 | $9.52 |
| Resistance Level | $25.40 | $10.13 |
| Average True Range (ATR) | 0.80 | 0.37 |
| MACD | 0.03 | 0.12 |
| Stochastic Oscillator | 59.84 | 82.90 |
Price Performance
Historical ComparisonAbout CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About CRGY Crescent Energy Company
Crescent Energy Co is an energy company committed to delivering value for shareholders through disciplined growth, acquisition ideas, and the consistent return of capital. Its long-life, balanced portfolio combines stable cash flows from low-decline production with deep, high-quality development inventory. The Company's investing and operating activities are focused in Texas and the Rocky Mountain region.